Page 438 - medicina-integrativa_compress

CAPÍTULO 39 OBESIDAD 439

50. Lujan JA, Frutos MD, Hernandez Q, et al: Laparoscopic versus open 67. Crawford V, Scheckenbach R, Preuss HG: Effects of niacin-bound
gastric bypass in the treatment of morbid obesity: A randomized chromium supplementation on body composition in overweight
prospective study. Ann Surg 239:433-437, 2004. African-American women. Diabetes Obes Metab 1:331-337, 1999.
51. Schauer P, Ikramuddin S, Hamad G, et al: The learning curve for 68. Vita PM, Restelli A, Caspani P, et al: Chronic use of glucomannan in
laparoscopic Roux-en-Y gastric bypass is 100 cases. Surg Endosc the dietary treatment of severe obesity. Minerva Med 83:135-139, 1992.
17:212-215, 2003. 69. Walsh DE, Yaghoubian V, Behforooz A: Effect of glucomannan on
52. Ren CJ, Weiner M, Allen JW: Favorable early results of gastric banding obese patients: A clinical study. Int J Obes 8:289-293, 1984.
for morbid obesity: The American experience. Surg Endosc 18: 70. Cairella M, Marchini G: Evaluation of the action of glucomannan on
542-546, 2004. metabolic parameters and on the sensation of satiation in overweight
53. Rubenstein RB: Laparoscopic adjustable gastric banding at a U.S. and obese patients. Clin Ter (Italian) 146:269-274, 1995.
center with up to 3-year follow-up. Obes Surg 12:380-384, 2002. 71. Rodriguez-Moran M, Guerrero-Romero F, Lazcano-Burciaga G:
54. Gatchell RJ, Turk DC: Interdisciplinary treatment of chronic pain Lipid- and glucose-lowering efficacy of plantago psyllium in type II
patients. In Gatchell RJ, Turk DK (eds): Psychosocial Factors in Pain: diabetes. J Diabetes Complications 12:273-278, 1998.
Critical Perspectives. New York, Guilford Press, 1999, pp 435-444. 72. Pittler MH, Ernst E: Guar gum for body weight reduction: Meta-
55. Blanck HM, Khan LK, Serdula MK: Use of nonprescription weight loss analysis of randomized trials. Am J Med 110:724-730, 2001.
products: Results from a multi-state survey. JAMA 286:930-935, 1998. 73. Lowenstein JM: Effect of (-)-hydroxycitrate on fatty acid synthesis by
56. Category report: OTC diet/weight loss. Drug Store News, May 20, rat liver in vivo. J Biol Chem 246:629-632, 1971.
2002, p 44. 74. Mattes RD, Bormann L: Effects of (-)-hydroxycitric acid on appetitive
57. Saper R, Phillips R, Eisenberg D: Common dietary supplements for variables. Physiol Behav 71:87-94, 2000.
weight loss. Am Fam Physician 70:1731-1738, 2004. 75. Heymsfield SB, Allison DB, Vasselli JR, et al: Garcinia cambogia
58. Pittler MH, Ernst E: Dietary supplements for body-weight reduction: (hydroxycitric acid) as a potential antiobesity agent: A randomized
A systematic review. Am J Clin Nutr 79:529-536, 2004. controlled trial. JAMA 280:1596-1600, 1998.
59. Bent S, Tiedt TN, Odden MC, et al: The relative safety of ephedra 76. Delany JP, Blohm F, Truett AA, et al: Conjugated linoleic acid rapidly
compared with other herbal products. Ann Intern Med 138: reduces body fat content in mice without affecting energy intake,
468-471, 2003. Am J Physiol 276:R1172-R1179, 1999.
60. Haller CA, Benowitz NL: Adverse cardiovascular and central nervous 77. Blankson H, Stakkestad JA, Fagertun H, et al: Conjugated linoleic
system events associated with dietary supplements containing acid reduces body fat mass in overweight and obese humans. J Nutr
ephedra alkaloids. N Engl J Med 343:1833-1838, 2000. 130:2943-2988, 2000.
61. Shekelle PG, Hardy ML, Morton SC, et al: Efficacy and safety of 78. Kalman D, Colker CM, Wilets I, et al: The effects of pyruvate
ephedra and ephedrine for weight loss and athletic performance: supplementation on body composition in overweight individuals.
A meta-analysis. JAMA 289:1537-1545, 2003. Nutrition 15:337-340, 1999.
62. McBride BF, Karapanos AK, Krudysz A, et al: Electrocardiographic 79. Gades MD, Stern JS: Chitosan supplementation and fecal fat
and hemodynamic effects of a multicomponent dietary supplement excretion in men. Obes Res 11:683-688, 2003.
containing ephedra and caffeine: A randomized controlled trial. 80. Pittler MH, Abbot NC, Harkness EF, et al: Randomized, double-blind
JAMA 291:216-221, 2004. trial of chitosan for body weight reduction. Eur J Clin Nutr 53:
63. Boozer CN, Daly PA, Homel P, et al: Herbal ephedra/caffeine for 379-381, 1999.
weight loss: A 6-month randomized safety and efficacy trial. 81. Sansone RA: Complications of hazardous weight-loss methods. Am
Int J Obes Relat Metab Disord 26:593-604, 2002. Fam Physician 30:141-146, 1984.
64. Anderson RA: Effects of chromium on body composition and weight 82. Lacey J, Tershakovec A, Foster G: Acupuncture for the treatment of
loss. Nutr Rev 56:266-270, 1998. obesity: A review of the evidence. Intl J Obes Rel Metab Dis 27:
65. Bahadori B, Wallner S, Schneider H, et al: Effect of chromium yeast 419-427, 2003.
and chromium picolinate on body composition of obese, non- 83. Mazzoni R, Mannucci E, Rizzello SM, et al: Failure of acupuncture in the
diabetic patients during and after a formula diet. Acta Med Austr treatment of obesity: A pilot study. Eating Weight Dis 4:198-202, 1999.
24:185-187, 1997. 84. van Dam RM, Rimm EB, Willett WC, et al: Dietary patterns and
66. Pasman WJ, Westerterp-Plantenga MS, Saris WH: The effectiveness risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med
of long-term supplementation of carbohydrate, chromium, fibre and 136:201-209, 2002.
caffeine on weight maintenance. Int J Obes Relat Metab Disord 85. Jakicic JM, Otto AD: Physical activity considerations for the treatment
21:1143-1151, 1997. and prevention of obesity. Am J Clin Nutr 82(Suppl):226S-229S, 2005.

© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.